CAMBREX CORP 4

4 · CAMBREX CORP · Filed Jun 8, 2017

Form 4

Period: 2017-06-06

Director

Transactions

Exercise/Conversion
Common Stock
2017-06-06$12.90/sh+7,361$94,957→ 74,662 total
Exercise/Conversion
Common Stock
2017-06-06$21.70/sh+5,643$122,425→ 80,305 total
Exercise/Conversion
Stock Option (right to buy)
2017-06-06+3,038→ 0 total
Exercise: $41.23From: 2015-10-29Exp: 2022-04-28→ Common Stock (3,038 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-06-06+4,614→ 0 total
Exercise: $45.12From: 2016-10-21Exp: 2023-04-20→ Common Stock (4,614 underlying)
Exercise/Conversion
Common Stock
2017-06-06$45.12/sh+4,614$208,184→ 87,957 total
Exercise/Conversion
Stock Option (right to buy)
2017-06-06+7,361→ 0 total
Exercise: $12.90From: 2013-10-25Exp: 2020-04-25→ Common Stock (7,361 underlying)
Exercise/Conversion
Common Stock
2017-06-06$41.23/sh+3,038$125,242→ 83,343 total
Sale
Common Stock
2017-06-06$55.95/sh−20,656$1,155,732→ 67,301 total
Exercise/Conversion
Stock Option (right to buy)
2017-06-06+5,643→ 0 total
Exercise: $21.70From: 2014-10-24Exp: 2021-04-28→ Common Stock (5,643 underlying)

Footnotes (1)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.90 to $56.051 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4

Documents

1 file